publication venue for
- Modulation of canonical Wnt signaling regulates peribiliary mesenchymal identity during homeostasis and injury.. 8. 2024
- Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals.. 7. 2023
- MELD, MELD 3.0, versus Child score to predict mortality after acute variceal hemorrhage: A multicenter US cohort.. 7. 2023
- Invasive fungal infections in liver diseases.. 7. 2023
- Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores.. 7. 2023
- Evaluating sleep in covert encephalopathy with wearable technology: results from the WATCHES study.. 7. 2023
- Prospective study of a case-finding algorithm to detect NAFLD with advanced fibrosis in primary care patients.. 7. 2023
- Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.. 7. 2023
- Clinical and demographic predictors of survival for fibrolamellar carcinoma patients-A patient community, registry-based study.. 6. 2022
- A missense mutation in the proprotein convertase gene furinb causes hepatic cystogenesis during liver development in zebrafish.. 6. 2022
- Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017-2018.. 6. 2022
- Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC. 2022
- Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learning.. 6. 2022
- Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort.. 5. 2021
- Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.. 5. 2021
- COVID-19 Aftershocks on Alcohol-Associated Liver Disease: An Early Cross-Sectional Report From the U.S. Epicenter.. 5. 2021
- Identification of Quantifiable Predictors of Relapse in Patients with Alcohol-Associated Liver Disease.. 5. 2021
- Liver Injury in Patients Hospitalized with Coronavirus Disease 2019 Correlates with Hyperinflammatory Response and Elevated Interleukin-6.. 5. 2020
- Hepatitis C Virus Infection in Populations With Liver-Related Diseases in the Middle East and North Africa.. 4. 2020
- Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass?. 4. 2020
- Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET Analysis.. 3. 2019
- Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In Vivo and In Vitro.. 3. 2019
- Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts.. 2. 2018
- Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitis.. 2. 2018
- Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohort.. 2. 2018
- Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease.. 2. 2018
- Role of Aramchol in steatohepatitis and fibrosis in mice.. 1. 2017
- Nicotinamide N-methyltransferase expression decreases in iron overload, exacerbating toxicity in mouse hepatocytes.. 1. 2017
- Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million Tests. 2019
- Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis. 2023
- Safety and tolerability of obeticholic acid in chronic liver disease: a pooled analysis of 1878 individuals. 2023
- Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment. 2019